Mutagenicity of the halogenated olefin, 2-bromo-2-chloro-1,1-difluoroethylene, a presumed metabolite of the inhalation anesthetic halothane
- PMID: 417917
- PMCID: PMC1475352
- DOI: 10.1289/ehp.772165
Mutagenicity of the halogenated olefin, 2-bromo-2-chloro-1,1-difluoroethylene, a presumed metabolite of the inhalation anesthetic halothane
Abstract
The presumed halothane metabolite, 2-bromo-1,1-difluoroethylene, produces both base substitution and frameshift mutations in Salmonella typhimurium. Direct mutagenesis of isolated DNA also was observed by using a Bacillus subtils transformation assay to score the production of mutagenic lesions in transforming DNA.
Similar articles
-
Mutagenicity of the halogenated olefin, 2-bromo-2-chloro-1,1-difluoroethylene, a presumed metabolite of the inhalation anesthetic halothane.Mutat Res. 1978 Aug;54(1):17-22. doi: 10.1016/0165-1161(78)90129-2. Mutat Res. 1978. PMID: 97524 No abstract available.
-
Mutagenicity studies with volatile metabolites of halothane.Anesthesiology. 1979 Nov;51(5):424-9. doi: 10.1097/00000542-197911000-00011. Anesthesiology. 1979. PMID: 386857
-
Lack of mutagenicity of two possible metabolites of halothane.Anesthesiology. 1979 Jan;50(1):9-12. doi: 10.1097/00000542-197901000-00003. Anesthesiology. 1979. PMID: 367217
-
Genotoxic and mutagenic assays of halothane metabolites in Bacillus subtilis and Salmonella typhimurium.Anesthesiology. 1980 Jul;53(1):31-9. doi: 10.1097/00000542-198007000-00007. Anesthesiology. 1980. PMID: 6770720 No abstract available.
-
The genotoxicity of ambient outdoor air, a review: Salmonella mutagenicity.Mutat Res. 2004 Nov;567(2-3):347-99. doi: 10.1016/j.mrrev.2004.08.002. Mutat Res. 2004. PMID: 15572287 Review.
Cited by
-
Occupational exposure to volatile anaesthetics: epidemiology and approaches to reducing the problem.CNS Drugs. 2001;15(3):197-215. doi: 10.2165/00023210-200115030-00004. CNS Drugs. 2001. PMID: 11463128 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources